Palisade Bio Inc (PALI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2017 | 12-2016 | 09-2016 | 06-2016 | 03-2016 | |
| Sales | 3 | 9 | 3 | 3 | 3 |
| Gross Profit | 3 | 9 | 3 | 3 | 3 |
| Operating Expenses | 4,235 | 5,661 | 4,920 | 3,837 | 6,236 |
| Operating Income | -4,232 | -5,652 | -4,917 | -3,834 | -6,234 |
| Interest Expense | 139 | 192 | 241 | 322 | 387 |
| Other Income | -3,197 | 448 | -63 | 304 | 14 |
| Pre-tax Income | -7,567 | -5,396 | -5,220 | -3,853 | -6,606 |
| Net Income Continuous | -7,567 | -5,396 | -5,220 | -3,853 | -6,606 |
| Net Income | $-7,567 | $-5,396 | $-5,220 | $-3,853 | $-6,606 |
| EPS Basic Total Ops | -61,157.18 | -48,565.99 | -53,062.85 | -42,270.41 | -83,641.45 |
| EPS Basic Continuous Ops | -61,087.55 | -47,460.17 | -53,140.55 | -42,560.28 | -83,940.33 |
| EPS Diluted Total Ops | -61,157.18 | -48,565.99 | -53,062.85 | -42,270.41 | -83,641.45 |
| EPS Diluted Continuous Ops | -61,087.55 | -47,460.17 | -53,140.55 | -42,560.28 | -83,940.33 |
| EBITDA(a) | $-4,072 | $-5,526 | $-4,740 | $-3,728 | $-5,959 |